Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 133, Issue 3
January 17 2019
Issue Cover

Table of Contents

BLOOD COMMENTARIES

THROMBOSIS AND HEMOSTASIS
New plugs for CCM bleeds
Victoria L. Bautch
View Articletitled, New plugs for CCM bleeds
CLINICAL TRIALS AND OBSERVATIONS
AL amyloidosis cardiac staging updated using BNP
Clinical Trials & Observations
Christopher P. Venner
View Articletitled, AL amyloidosis cardiac staging updated using BNP
Hematopoiesis and Stem Cells
Timing’s everything in light, location, and cells
Heather A. O’Leary
View Articletitled, Timing’s everything in light, location, and cells
Lymphoid Neoplasia
Localized FL: how long in response to be cured?
Silvia Montoto
View Articletitled, Localized FL: how long in response to be cured?
PLATELETS AND THROMBOPOIESIS
TMX1: a new vascular thiol isomerase
Philip J. Hogg
View Articletitled, TMX1: a new vascular thiol isomerase
Red Cells, Iron, and Erythropoiesis
Resolving inflammation and pain of sickle cell
Gabrielle Fredman
View Articletitled, Resolving inflammation and pain of sickle cell

PLENARY PAPER

THROMBOSIS AND HEMOSTASIS
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice
Miguel Alejandro Lopez-Ramirez,Angela Pham,Romuald Girard,Tine Wyseure,Preston Hale,Atsuki Yamashita,Janne Koskimäki,Sean Polster,Laleh Saadat,Ignacio A. Romero,Charles T. Esmon,Frederic Lagarrigue,Issam A. Awad,Laurent O. Mosnier,Mark H. Ginsberg
View Articletitled, Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice
Supplemental data

HOW I TREAT

How I treat infant leukemia
Patrick Brown,Rob Pieters,Andrea Biondi
View Articletitled, How I treat infant leukemia

CLINICAL TRIALS AND OBSERVATIONS

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis
CME Clinical Trials & Observations
Brian Lilleness,Frederick L. Ruberg,Roberta Mussinelli,Gheorghe Doros,Vaishali Sanchorawala
View Articletitled, Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis

HEMATOPOIESIS AND STEM CELLS

Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes
Andrés García-García,Claudia Korn,María García-Fernández,Olivia Domingues,Javier Villadiego,Daniel Martín-Pérez,Joan Isern,José A. Bejarano-García,Jacques Zimmer,José A. Pérez-Simón,Juan J. Toledo-Aral,Tatiana Michel,Matti S. Airaksinen,Simón Méndez-Ferrer
View Articletitled, Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes
Supplemental data

LYMPHOID NEOPLASIA

Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG
Clinical Trials & Observations
Jessica L. Brady,Michael S. Binkley,Carla Hajj,Monica Chelius,Karen Chau,Alex Balogh,Mario Levis,Andrea Riccardo Filippi,Michael Jones,Michael Mac Manus,Andrew Wirth,Masahiko Oguchi,Anders Krog Vistisen,Therese Youssef Andraos,Andrea K. Ng,Berthe M. P. Aleman,Seo Hee Choi,Youlia Kirova,Sara Hardy,Gabriele Reinartz,Hans T. Eich,Scott V. Bratman,Louis S. Constine,Chang-Ok Suh,Bouthaina Dabaja,Tarec C. El-Galaly,David C. Hodgson,Umberto Ricardi,Joachim Yahalom,Richard T. Hoppe,N. George Mikhaeel
View Articletitled, Definitive radiotherapy for localized follicular lymphoma staged by <sup>18</sup>F-FDG PET-CT: a collaborative study by ILROG
Supplemental data

PLATELETS AND THROMBOPOIESIS

The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses
Brief Report
Zhenzhen Zhao,Yi Wu,Junsong Zhou,Fengwu Chen,Aizhen Yang,David W. Essex
View Articletitled, The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1
Alessandro Matte,Antonio Recchiuti,Enrica Federti,Bérengère Koehl,Thomas Mintz,Wassim El Nemer,Pierre-Louis Tharaux,Valentine Brousse,Immacolata Andolfo,Alessia Lamolinara,Olga Weinberg,Angela Siciliano,Paul C. Norris,Ian R. Riley,Achille Iolascon,Charles N. Serhan,Carlo Brugnara,Lucia De Franceschi
View Articletitled, Resolution of sickle cell disease–associated inflammation and tissue damage with 17<em>R</em>-resolvin D1
Supplemental data

TRANSPLANTATION

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice
Anusara Daenthanasanmak,Supinya Iamsawat,Paramita Chakraborty,Hung D. Nguyen,David Bastian,Chen Liu,Shikhar Mehrotra,Xue-Zhong Yu
View Articletitled, Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice
Supplemental data

LETTER TO BLOOD

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome
Marie Passet,Nicolas Boissel,François Sigaux,Colombe Saillard,Mario Bargetzi,Ibrahima Ba,Xavier Thomas,Carlos Graux,Yves Chalandon,Thibaut Leguay,Etienne Lengliné,Johanna Konopacki,Samuel Quentin,Eric Delabesse,Marina Lafage-Pochitaloff,Cédric Pastoret,Nathalie Grardel,Vahid Asnafi,Véronique Lhéritier,Jean Soulier,Hervé Dombret,Emmanuelle Clappier,on behalf of the Group for Research on Adult ALL (GRAALL)
View Articletitled, <em>PAX5</em> P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome
Supplemental data

BLOOD WORK

Erythrophagocytosis on the peripheral blood smear
Mark Grech,David James Camilleri
View Articletitled, Erythrophagocytosis on the peripheral blood smear

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

BNP-based staging system in AL amyloidosis
CME
View Articletitled, BNP-based staging system in AL amyloidosis
All Issues

Advertisement

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy
NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients
Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis
How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction
How I manage major hemorrhage

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement